Pharmaceutical

Silence Therapeutics gets grant for compound for rna interference therapy in treating liver disease

Discover the groundbreaking patent by Silence Therapeutics Plc for a compound revolutionizing RNA interference therapy. Learn how formula (II) is paving the way for targeted treatment of liver disease and genetic disorders.

Jun 12, 2024 - 04:00
Silence Therapeutics gets grant for compound for rna interference therapy in treating liver disease
Discover the groundbreaking patent by Silence Therapeutics Plc for a compound revolutionizing RNA interference therapy. Learn how formula (II) is paving the way for targeted treatment of liver disease and genetic disorders.
Read the original article

Tags:

Previous Article

BioMarin Pharmaceutical gets grant for treatment of adolescent PKU patients usin...

Next Article

Syros Pharmaceuticals gets grant for CDK7 inhibitors for treating cancer and oth...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Health insurance CEOs set another record for pay in 2022

STAT+: Health insurance CEOs set another record for pay...

Apr 27, 2023

STAT+: Flow Neuroscience shows promising results in trial of brain-stimulation headset for depression

STAT+: Flow Neuroscience shows promising results in tri...

Aug 1, 2023

STAT+: Brigham and Women’s exec opens up about the Dana-Farber Cancer Institute split, and what it means for the future of cancer care

STAT+: Brigham and Women’s exec opens up about the Dana...

Sep 28, 2023